Annual report pursuant to Section 13 and 15(d)

Revenue (Tables)

v3.23.1
Revenue (Tables)
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Summary of Deferred Revenue Activity
Deferred revenue consisted of the following:
December 31, 2022 December 31, 2021
Deferred extended maintenance and support $ 2,124  $ 2,349 
Deferred royalties —  280 
Deferred device and advances 29  66 
Total deferred revenues 2,153  2,695 
Less current portion (1,121) (1,220)
Deferred revenues, non-current $ 1,032  $ 1,475 
 
Deferred revenue activity consisted of the following for the years ended December 31, 2021 and December 31, 2022:
Year Ended December 31, 2022 Year Ended December 31, 2021
Beginning balance $ 2,695  $ 3,302 
Deferral of revenue 1,397  1,189 
Recognition of deferred revenue (1,939) (1,796)
Ending balance $ 2,153  $ 2,695 
Summary of Disaggregation of Revenue
The following table disaggregates the Company’s revenue by major source for the year ended December 31, 2022:
  EksoHealth EksoWorks Total
Device revenue $ 8,305  $ 588  $ 8,893 
Service and support 1,923  —  1,923 
Subscriptions 967  136  1,103 
Parts and other 528  358  886 
Collaborative arrangements 107  —  107 
  $ 11,830  $ 1,082  $ 12,912 

The following table disaggregates the Company’s revenue by major source for the year ended December 31, 2021:
  EksoHealth EksoWorks Total
Device revenue $ 6,428  $ 1,138  $ 7,566 
Service and support 1,891  —  1,891 
Subscriptions 723  254  977 
Parts and other 578  104  682 
Collaborative arrangements 130  —  130 
  $ 9,750  $ 1,496  $ 11,246